-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Serina Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
- Serina Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $988K, a 98700% increase year-over-year.
- Serina Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $2.6M, a 10280% increase year-over-year.
- Serina Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $2.6M, a 10280% increase from 2023.
- Serina Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $25K, a 96.7% decline from 2022.
- Serina Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $760K, a 24.2% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)